| Date | Title | Description |
| 25.07.2025 | Cooler Heads Secures $11M: Revolutionizing Chemotherapy Patient Care | Cooler Heads secured $11 million in Series A funding. This fuels the expansion of Amma, their FDA-cleared portable scalp cooling system. Amma prevents chemotherapy-induced hair loss. It offers a continuous, accessible solution. This investm... |
| 23.07.2025 | Cooler Heads: $11 Million Series A Raised For Scalp Cooling Technology To Help Chemotherapy Patients | Cooler Heads, a medical device company, has raised $11 million in an oversubscribed Series A funding round to expand the manufacturing of Amma, the only FDA-cleared Portable Scalp Cooling System. Led by Mutual Capital Partners, the round al... |
| 22.07.2025 | Cooler Heads Raises $11M in Series A Funding | Amma provides infusion centers and patients the flexibility to scalp cool where it is most convenient.
Cooler Heads, a San Diego, CA-based medical device company, raised $11M in Series A funding.
The round was led by Mutual Capital Partners... |
| 15.03.2016 | Daily funding roundup - March 15, 2016 | Couchbase secured $30M; Next Insurance landed $13M; Skyport Systems raised $30M
Skyport Systems, provider of secure server systems, raised a $30 million Series C funding round led by GV (Google Ventures) with participation from Cisco Invest... |
| 13.10.2015 | MiNDERA Closes $1M Seed Financing | MiNDERA Corp., a South San Francisco, CA-based developer of non-invasive molecular diagnostics for dermatology and skin-related cancers, closed a $1m seed financing round.
Backers included Scientific Health Development and other individual ... |
| 07.01.2014 | Incubator with six venture-backed spinouts seeks 2014 exit, unveils new sepsis spinout | The six venture-backed spinouts include:
Baronova, a startup trying for weight loss devices that are both non-surgical and non-pharma. The company closed a $27.3 million Series C round in February 2013, which was led by Boston Scientific (B... |
| 09.11.2012 | Rival’s setback provides unexpected advantage for drug developer’s kidney injury therapeutic | Complexa CEO Joshua Tarnoff presented its kidney disease and kidney injury therapeutic at the Greater Philadelphia Alliance for Capital and Technology’s IMPACT conference this week.
The company is finishing off pre-clinical studies in the r... |
| - | Incubator with six venture-backed spinouts seeks 2014 exit, unveils new sepsis spinout | TheraNova is a San Francisco-based sandbox incubator and capital technology developer for medical devices. With one exception, all the ideas for technology are internally generated, CEO Dr. Daniel Burnett said. That’s led to all its medical... |
| - | Rival’s setback provides unexpected advantage for drug developer’s kidney injury therapeutic | Frequently, the path to commercial approval for a biopharmaceutical startup’s drug is filled with adversity. But the drug development industry is also filled with unexpected twists. Last month, Pittsburgh-based Complexa unexpectedly lost a ... |